Thrombosis risk in carriers of the factor V Leiden mutation: Is it associated with a defined skin color?

Pathology Research and Practice

Volumn 207, Issue 11, 2011, Pages 671-673

  Dashti, Ali A ^a   Jadaon, Mehrez M ^a   Abdulsamad, Abdulsamad M ^b   Dashti, Mohammad H ^c   Lewis, Hend L ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

^b AL AMIRI HOSPITAL   (Kuwait)

^c MUBARAK AL KABEER HOSPITAL   (Kuwait)

Author keywords

Arab; Factor V Leiden mutation; Kuwait; Skin color

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN;

ARAB; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CONTROLLED STUDY; GENE FREQUENCY; GENE MUTATION; GENETIC MARKER; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN EXPERIMENT; ISRAEL; JORDAN; KUWAIT; LEBANON; MIDDLE EAST; NORMAL HUMAN; POINT MUTATION; PREVALENCE; REAL TIME POLYMERASE CHAIN REACTION; SKIN COLOR; SWEDEN; SYRIAN ARAB REPUBLIC; THROMBOSIS;

ARABS; FACTOR V; GENE FREQUENCY; GENOTYPE; HETEROZYGOTE; HUMANS; KUWAIT; MUTATION; PREVALENCE; REAL-TIME POLYMERASE CHAIN REACTION; RISK FACTORS; SKIN PIGMENTATION; THROMBOSIS;

EID: 82755182533     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2011.07.013     Document Type: Article

References (39)

1. Alakoc Y.D., Aka P.S., Egin Y., Akar N. Factor V Leiden in an Urartian, dating back to 1000 BC. Clin. Appl. Thromb. Hemost. 2010, 16:679-683.
2. Almawi W.Y., Keleshian S.H., Borgi L., Fawaz N.A., Abboud N., Mtiraoui N., et al. Varied prevalence of factor V G1691A (Leiden) and prothrombin G20210A single nucleotide polymorphisms among Arabs. J. Thromb. Thrombol. 2005, 20:163-168.
3. Almawi W.Y., Tamim H., Kreidy R., Timson G., Rahal E., Nabulsi M., Finan R.R., Irani-Hakime N. A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis. J. Thromb. Thrombol. 2005, 19:189-196.
4. Arruda V.R., Annichino-Bizzacchi J.M., Costa F.F., Reitsma P.H. Factor V Leiden, (FVQ 506) is common in a Brazilian population. Am. J. Hematol. 1995, 49:242-243.
5. Awidi A., Shannak M., Bseiso A., Kailani M.A.M., Kailani M.A., Omar N., Anshasi B., Sakarneh N. High prevalence of factor V Leiden in healthy Jordanian Arabs. Thromb. Haemost. 1999, 41:582-584.
6. Bennett J.A., Palmer L.J., Musk A.W., Erber W.N. Prevalence of factor V Leiden and prothrombin 20210A mutations in indigenous Australians. Thromb. Haemost. 2001, 86:1592-1593.
7. Bertina R.M., Koeleman B.P.C., Koster T., Rosendaal F.R., Dirven R.J., de Ronde H.D., van der Velden P.A., Reitsma P.H. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994, 369:64-67.
8. Castoldi E., Lunghhi B., Mingozzi F. New coagulation factor V gene polymorphisms define a single and infrequent haplotype underlying the factor V Leiden mutation in Mediterranean populations and Indians. Thromb. Haemost. 1997, 78:1037-1041.
9. Cox M.J., Rees D.C., Martinson J.J., Clegg J.B. Evidence of a single origin of factor V Leiden. Br. J. Haematol. 1996, 92:1022-1025.
10. Dashti A.A., Jadaon M.M. Race differences in the prevalence of the factor V Leiden mutation in Kuwaiti nationals. Mol. Biol. Rep. 2010, doi:101007/s11033-010-0474-7.
11. Dashti A.A., Jadaon M.M., Lewis H.L. Factor V Leiden mutation in Arabs in Kuwait by real-time PCR: different values for different Arabs. J. Hum. Genet. 2010, 55:232-235.
12. De Maat M.P.M., Kluft C., Jespersen J., Gram J. World distribution of factor V Leiden mutation. Lancet 1996, 347:58.
13. Dzimiri N., Meyer B. World distribution of factor V Leiden. Lancet 1996, 347:481-482.
14. Eid S.S., Rihani G. Prevalence of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations in 200 healthy Jordanians. Clin. Lab. Sci. 2004, 17:200-202.
15. Eid S.S., Shubeilat S.S.T. Prevalence of Factor V Leiden, prothrombin G20210A, and MTHFR G677A among 594 thrombotic Jordanian patients. Blood Coagul. Fibrinolysis 2005, 16:417-421.
16. El-Karaksy H., El-Koofy N., El-Hawary M., Mostafa A., Aziz M., El-Shabrawi M., Mohsen N.A., Kotb M., El-Raziky M., El-Sonoon M.A., A-Kader H. Prevalence of factor V Leiden mutation and other hereditary thrombophilic factors in Egyptian children with portal vein thrombosis: results of a single-center case-control study. Ann. Hematol. 2004, 83:712-715.
17. Finan R.R., Tamim H., Ameen G., Sharida H.E., Rashid M., Almawi W.Y. Prevalence of factor V G1691A (factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population. Am. J. Hematol. 2002, 71:300-305.
18. Fitzpatrick T.B. Soleil et peau. J. Med. Esthet. 1975, 2:33-34.
19. Ho C.H., Chau W.K., Hsu H.C., Gau J.P., Chih C.M. Prevalence of factor V Leiden in the Chinese population. Zhonghua Yi Xue Za Zhi 1999, 62:875-878.
20. Irani-Hakime N., Tamim H., Elias G., Finan R.R., Daccache J.L., Almawi W.Y. High prevalence of factor V mutation (Leiden) in the Eastern Mediterranean. Clin. Chem. 2000, 46:134-136.
21. Jablonski N.G., Chaplin G. Colloquium paper: human skin pigmentation as an adaptation to UV radiation. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:8962-8968.
22. Jadaon M.M., Dashti A.A., Lewis H.L. High prevalence of activated protein C resistance and factor V Leiden mutation in Arab population and patients with venous thrombosis in Kuwait. Diag. Mol. Pathol. 2010, 19:180-183.
23. Norton H.L., Kittles R.A., Parra E., McKeigue P., Mao X., Cheng K., Canfield V.A., Bradley D.G., McEvoy B., Shriver M.D. Genetic evidence for the convergent evolution of light skin in Europeans and East Asians. Mol. Biol. Evol. 2007, 24:710-722.
24. Pathare A., Al Kindi A., Al Haddabi H., Dennison D., Bayoumi R., Muralitharan S. Hereditary thrombophilia in ethnic Omani patients. Am. J. Hematol. 2006, 81:101-106.
25. Pepe G., Rickards O., Vanegas O.C., Brunelli T., Gori A.M., Giusti B., Attanasio M., Prisco D., Gensini G.F., Abbate R. Prevalence of factor V Leiden mutation in non-European populations. Thromb. Haemost. 1997, 77:329-331.
26. Rees D.C., Cox M., Clegg J.B. World distribution of factor V Leiden. Lancet 1995, 346:1133-1134.
27. Relethford J.H. Human skin color diversity is highest in sub-Saharan African populations. Hum. Biol. 2000, 72:773-780.
28. Ridker P.M., Miletich J.P., Hennekens C.H., Buring J.E. Ethnic distribution of Factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening. JAMA 1997, 277:1305-1307.
29. Rosen E., Renbaum P., Heyd J., Levy-Lahad E. High frequency of factor V Leiden in a population of Israeli Arabs. Thromb. Haemost. 1999, 82:1768.
30. Settin A., Dowaidar M., El-Baz R., Abd-Al-Samad A., El-Sayed I., Nasr M. Frequency of factor V Leiden mutation in Egyptian cases with myocardial infarction. Hematology 2008, 13:170-174.
31. Taher A., Khalil I., Shamseddine A., El-Ahdab F., Bazarbachi A. High prevalence of Factor V Leiden mutation among healthy individuals and patients with deep venous thrombosis in Lebanon: is the eastern Mediterranean region the area of origin of this mutation?. Thromb. Haemost. 2001, 86:723-724.
32. Tamim H., Finan R.R., Almawi W.Y. Prevalence of two thrombophilia predisposing mutations: factor V G1691A (R506Q; Leiden) and prothrombin G20210A, among healthy Lebanese. Thromb. Haemost. 2002, 88:691-692.
33. Valenzuela R.K., Henderson M.S., Walsh M.H., Garrison N.A., Kelch J.T., Cohen-Barak O., Erickson D.T., Meaney F., Bruce Walsh J., Cheng K.C., Ito S., Wakamatsu K., Frudakis T., Thomas M., Brilliant M.H. Predicting phenotype from genotype: normal pigmentation. J. Forensic Sci. 2010, 55:315-322.
34. Wehrle-Haller B. The role of kit-ligand in melanocyte development and epidermal homeostasis. Pigment Cell Res. 2003, 16:287-296.
35. Zama T., Murata M., Ono F., Watanabe K., Watanabe R., Moriki T., Yokoyama K., Tokuhira M., Ikeda Y. Low prevalence of activated protein C resistance and coagulation factor V Arg506 to Gln mutation among Japanese patients with various forms of thrombosis, and normal individuals. Int. J. Hematol. 1996, 65:71-78.
36. Zivelin A., Griffin J.H., Xu X., Pabinger I., Samama M., Conard J., Brenner B., Eldor A., Seligsohn U. A single genetic origin for a common Caucasian risk factor for venous thrombosis. Blood 1997, 89:397-402.
37. Zivelin A., Mor-Cohen R., Kolvalsky V., Kornbrot N., Conard J., Peyvandi F., Kyrle P.A., Bertina R., Peyvandi F., Emmerich J., Seligsohn U. Prothrombin 20210GA is an ancestral prothrombotic mutation that occurred in whites approximately 24,000 years ago. Blood 2006, 107:4666-4668.
38. Zivelin A., Rosenberg N., Faier S., Kornbrot N., Peretz H., Mannhalter C., Horellou M., Seligsohn U. A single genetic origin for the common prothrombotic G20210 A polymorphism in the prothrombin gene. Blood 1998, 92:1119-1124.
39. Takahashi Y., Morita S., Yoshimura J., Watanabe M. A Geographic cline induced by negative frequency-dependent selection. BMC. Evol. Biol. 2011, 11:256.